>If…the need for lower cost drugs wasn't an issue then GTC would have a difficult time convincing investors that the company had a competitive advantage to exploit.<
In case anyone needs a reminder on the political impetus for lower-cost drugs, please see the big bad charts in #msg-23009572.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”